共 50 条
- [5] Sorafenib use in hepatitis B virus- or hepatitis C virus-related hepatocellular carcinoma: A propensity score matching study [J]. KAOHSIUNG JOURNAL OF MEDICAL SCIENCES, 2021, 37 (10): : 894 - 902
- [7] Transarterial Chemoembolization (TACE) Combined with Sorafenib versus TACE Alone for Unresectable Hepatocellular Carcinoma: A Propensity Score Matching Study [J]. JOURNAL OF CANCER, 2019, 10 (05): : 1189 - 1196